Systematic Financial Management’s Emergent Biosolutions EBS Stock Holding History

Systematic Financial Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,740	Closed	-$1.05M	–	631
2019 Q1	$1.05M	Buy	20,740 +895	+5%	+$52.8K	0.04%	483
2018 Q4	$1.18M	Sell	19,845 -4,035	-17%	-$260K	0.04%	337
2018 Q3	$1.57M	Sell	23,880 -1,550	-6%	-$90.4K	0.04%	310
2018 Q2	$1.28M	Sell	25,430 -885	-3%	-$46.1K	0.03%	485
2018 Q1	$1.39M	Sell	26,315 -11,965	-31%	-$596K	0.03%	437
2017 Q4	$1.78M	Sell	38,280 -3,265	-8%	-$137K	0.04%	290
2017 Q3	$1.68M	Buy	+41,545	New	+$1.5M	0.03%	317
2017 Q1	–	Sell	-53,740	Closed	-$1.76M	–	653
2016 Q4	$1.76M	Sell	53,740 -11,015	-17%	-$330K	0.03%	436
2016 Q3	$2.04M	Buy	64,755 +5,980	+10%	+$174K	0.03%	328
2016 Q2	$1.65M	Buy	+58,775	New	+$2.3M	0.02%	463

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Systematic Financial Management's EBS Position: Q2 2019 in Review

Systematic Financial Management sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 20,740 shares — an estimated $1.05M sold.

Systematic Financial Management first reported a position in EBS in Q2 2016 and held it in 10 quarters. The position peaked at $2.04M in Q3 2016. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

Systematic Financial Management reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
Systematic Financial Management sold 20,740 Emergent Biosolutions shares in Q2 2019, an estimated $1.05M.
Systematic Financial Management first reported a position in Emergent Biosolutions in Q2 2016 and held it in 10 quarters.
Systematic Financial Management's Emergent Biosolutions position peaked at $2.04M in Q3 2016.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Systematic Financial Management's 13F filing for Q2 2019, filed 26 Jul 2019.